A Case of Ceftriaxone-induced Obstructive Jaundice

Nakagawara, Hiroshi; Ogawa, Masahiro; Nakagawara, Akiko; Tamura, Akinori; Matsuoka, Sumiko; Moriyama, Mitsuhiko; Katayama, Nobuyuki; Nakata, Y

doi:10.4264/numa.71.436

Search citation statements

Order By: Relevance

Paper Sections

Select...

Discussion1

Citation Types

Supporting

Mentioning

Contrasting

Year Published

2019

Publication Types

Select...

Article1

Relationship

Self Cite0

Independent1

Authors

Journals

Cited by 1 publication

(1 citation statement)

References 10 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Second, patients who have a complicated background may be at greater risk of ceftriaxone‐associated pseudolithiasis. Case reports from Japan of ceftriaxone‐associated pseudolithiasis in adults are shown in Table . These patients have shown various underlying conditions, and most patients have been elderly.…”

Section: Discussionmentioning

confidence: 99%

Asymptomatic ceftriaxone‐associated pseudolithiasis

Sasaki

Sugimura

Shinoda

et al. 2019

J of Gen and Family Med

View full text Add to dashboard Cite

An 88‐year‐old woman with a history of meningioma and dementia was admitted with high fever, loss of appetite, and nausea in July. Urinary tract infection was suspected. Computed tomography (CT) showed no significant findings. Urinary findings improved with administration of ceftriaxone. However, high fever appeared on hospital day 28, and CT identified a gallbladder stone without any abdominal symptoms. We considered the possibility of ceftriaxone‐associated pseudolithiasis and changed pharmacotherapy to cefmetazole. CT on day 34 showed a reduction in the size of the gallbladder stone. Ceftriaxone‐associated pseudolithiasis might arise in the absence of abdominal symptoms, and clinicians should take the patient background and season into account when using this agent.

show abstract

Section: Discussionmentioning

confidence: 99%